Loss of an estrogen receptor isoform (ER(α)Δ3) in breast cancer and the consequences of its reexpression: Interference with estrogen-stimulated properties of malignant transformation

Molecular Endocrinology

Volumn 11, Issue 13, 1997, Pages 2004-2015

  Erenburg, I ^a   Schachter, B ^a   Mira Y Lopez, R ^a   Ossowski, L ^a,b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR; MESSENGER RNA;

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; ESTROGEN ACTIVITY; EXPRESSION VECTOR; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALIGNANT TRANSFORMATION; MOLECULAR CLONING; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RNA ANALYSIS;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0030778152     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/mend.11.13.0031     Document Type: Article

References (54)

1. Topper YJ, Freeman CS 1980 Multiple hormone interactions in the developmental biology of the mammary gland. Physiol Rev 60:1049-1106
2. Lippman ME, Dickson RB 1990 Regulation of normal and malignant breast epithelial proliferation. In: Growth Regulation of Cancer II. Alan R. Liss, Washington, DC, vol. 115:127-172
3. Truss M, Chelepakis G, Pina B, Barettino D, Bruggemeier U, Kalff M, Slater EP, Beato M 1992 Transcriptional control by steroid hormones. J Steroid Biochem Mol Biol 41:241-248
4. Kumar V, Green S, Stack G, Berry M, Jin JR, Chambon P 1987 Functional domains of the human estrogen receptor. Cell 51:941-951
5. Koenig RJ, Lazar MA, Hodin RA, Brent GA, Larsen PR, Chin WW, Moore DD 1989 Inhibition of thyroid hormone action by a non-hormone binding c-erbA protein generated by alternative RNA splicing. Nature 337:659-661
6. Mosselman S, Polman J, Dijkema R 1996 ERβ: identification and characterization of a novel human estrogen receptor. FEBS Lett 392:49-53
7. Leygue ER, Watson PH, Murphy LC 1996 Estrogen receptor variants in normal human mammary tissue. J Natl Cancer Inst 88:284-290
8. Fuqua SAW, Fitzgerald SD, Allred DC, Elledge RM, Nawaz Z, McDonnell DP, O'Malley BW, Greene GL, McGuire WL 1992 Inhibition of estrogen receptor action by a naturally occurring variant in human breast tumors. Cancer Res 52:483-486
9. Fuqua SAW, Fitzgerald SD, Chamness GC, Tandon AK, McDonnell DP, Nawaz Z, O'Malley BW, McGuire WL 1991 Variant human breast tumor estrogen receptor with constitutive transcriptional activity. Cancer Res 51:105-109
10. Castles CG, Fuqua SAW, Klotz DM, Hill SM 1993 Expression of a constitutively active estrogen receptor variant in the estrogen receptor negative BT-20 human breast cancer cell line. Cancer Res 53:5934-5939
11. Zhang QX, Borg A, Fuqua SAW 1993 An exon 5 deletion variant of the estrogen receptor frequently co-expressed with wild-type estrogen receptor in human breast cancers. Cancer Res 53:5882-5884
12. Parker MG, Rea D 1996 Effects of an exon 5 variant of the estrogen receptor in MCF7 breast cancer cells. Cancer Res 56:1556-1563
13. Daffada AAI, Dowsett M 1995 Tissue-dependent expression of a novel splice variant of the human oestrogen receptor. J Steroid Biochem Mol Biol 55:413-421
14. Villa E, Camellini L, Dugani A, Zucchi F, Grottola A, Merighi A, Buttafoco P, Losi L, Manenti F 1995 Variant estrogen receptor messenger RNA species detected in human primary hepatocellular carcinoma. Cancer Res 55:498-500
15. Koehorst SGA, Jacobs HM, Thijssen JHH, Blankenstein MA 1993 Wild type and alternatively spliced estrogen receptor messenger RNA in human meningioma tissue and MCF7 breast cancer cells. J Steroid Biochem Mol Biol 45:227-233
16. Daffada AAI, Johnston SR, Smith IE, Detre S, King N, Dowsett M 1995 Exon 5 deletion variant receptor messenger RNA expression in relation to tamoxifen resistance and progesterone receptor/pS2 status in human breast cancer. Cancer Res 55:288-293
17. Daffada AAI, Johnston SRD, Nicholls J, Dowsett M 1994 Detection of wild type and exon 5 deleted splice variant oestrogen receptor (ER) mRNA in ER-positive and negative breast cancer cell lines by reverse transcription/ polymerase chain reaction. J Mol Endocrinol 13:265-273
18. Dotzlaw H, Alkhalaf M, Murphy LC 1992 Characterization of estrogen receptor variant mRNAs from human breast cancers. Mol Endocrinol 6:773-785
19. Pfeffer U, Fecaroota N, Catagnetta L, Vidali G 1993 Estrogen receptor variant messenger RNA lacking exon 4 in estrogen responsive human breast cancer cell lines. Cancer Res 53:741-743
20. Wang Y, Miksicek RJ 1991 Identification of a dominant negative form of the human oestrogen receptor. Mol Endocrinol 5:1707-1715
21. Miksicek RJ, Lei Y, Wang Y 1993 Exon skipping gives rise to alternatively spliced forms of the estrogen receptor in breast tumor cells. Breast Cancer Res Treat 26:163-174
22. Friend KE, Ang LW, Shupnik MA 1995 Estrogen regulates the expression of several different estrogen receptor mRNA isoforms in rat pituitary. Proc Natl Acad Sci USA 92:4367-4371
23. Madsen MW, Reiter BE, Larsen SS, Bieand P, Lykkesfeldt AE 1997 Estrogen receptor messenger RNA splice variants are not involved in antiestrogen resistance in sublines of MCF-7 human breast cancer cells. Cancer Res 57:585-589
24. Pfeffer U, Fecarotta E, Vidali G 1995 Coexpression of multiple estrogen receptor variant messenger RNAs in normal and neoplastic breast tissues and in MCF-7 cells. Cancer Res 55:2158-2165
25. Tung L, Mohamed MK, Hoeffler JP, Takimoto GS, Horwitz KB 1993 Antagonist-occupied human progesterone B-receptors activate transcription without binding to progesterone response elements and are dominantly inhibited by A-receptors. Mol Endocrinol 7:1256-1265
26. Ince BA, Zhuang Y, Wrenn CK, Shapiro DJ, Katzenellenbogen BS 1993 Powerful dominant negative mutants of the human estrogen receptor. J Biol Chem 268:14026-14032
27. Schodin DJ, Zhuang Y, Shapiro DJ, Katzenellenbogen BS 1995 Analysis of mechanisms that determine dominant negative estrogen receptor effectiveness. J Biol Chem 270:31163-31171
28. Ince BA, Schodin DJ, Shapiro DJ, Katzenellenbogen BS 1995 Repression of endogenous estrogen receptor activity in MCF-7 human breast cancer cells by dominant negative estrogen receptors. Endocrinology 136:31194-3199
29. Taylor-Papadimitriou J, D'Souza B, Burchell J, Kyprianou N, Berdichevsky F 1993 The role of tumor-associated antigen in the biology and immunotherapy of breast cancer. Ann NY Acad Sci 698:31-47
30. Bartek J, Bartkova J, Kyprianou N, Lalani E-N, Staskova Z, Shearer M, Chang S, Taylor-Papadimitriou J 1991 Efficient immortalization of luminal epithelial cells from human mammary glands by introduction of simian virus 40 large tumor antigen with a recombinant retrovirus. Proc Natl Acad Sci USA 88:3520-3524
31. Stampfer M, Hallowes RC, Hackett AJ 1980 Growth of normal human mammary cells in culture. In Vitro 16: 415-425
32. Kirschmeier PT, Housey GM, Johnson MD, Perkins AS, Weinstein IB 1988 Construction and characterization of a retroviral vector demonstrating efficient expression of cloned cDNA sequences. DNA 7:219-225
33. Greene GL, Press MF 1986 Structure and dynamics of the estrogen receptor. J Steroid Biochem 24:1-7
34. Mira-Y-Lopez R, Osborne MP, DePalo AJ, Ossowski L 1991 Estradiol modulation of plasminogen activator production in organ cultures of human breast carcinomas: correlation with clinical outcome of anti-estrogen therapy. Int J Cancer 47:827-832
35. Burg B, Groot RP, Isbrucker L, Kruijer W, Laat SW 1990 Stimulation of tPA-responsive element activity by a cooperative action of insulin and estrogen in human breast cancer cells. Mol Endocrinol 4:1720-1726
36. Touitou I, Cavailles V, Garcia M, Defrenne A, Rocheford H 1989 Differential regulation of cathepsin D by sex steroids in mammary cancer and uterine cells. Mol Cell Endocrinol 66:231-238
37. Davis MD, Butler WB, Brooks SC 1995 Induction of tissue plasminogen activator mRNA and activity by structurally altered estrogens. J Steroid Biochem Mol Biol 52:421-430
38. Thompson EW, Reich R, Shima TB, Albini A, Graf J, Martin GR, Dickson RB, Lippman ME 1988 Differential regulation of growth and invasiveness of MCF7 breast cancer cells by anti-estrogen. Cancer Res 48:6764-6768
39. Ossowski L 1988 In vivo invasion of modified chorioallantoic membrane by tumor cells: the role of cell surface bound urokinase. J Cell Biol 107:2437-2445
40. Peterson OW, Hoyer PE, Deurs B 1987 Frequency and distribution of estrogen receptor positive cells in normal, non-lactating human breast tissue. Cancer Res 47: 5748-5751
41. Cullen KJ, Lippman ME 1991 Stromal-epithelial interactions in breast cancer. In: Dickson RB, Lippman ME (eds) Genes, Oncogenes, and Hormones: Advances in Cellular and Molecular Biology of Breast Cancer, Chapter 20. Kluwer Academic Publishers, pp 413-431
42. Haslam SZ 1991 Stromal-epithelial interactions in normal and neoplastic mammary gland. In: Dickson RB, Lippman ME (eds) Regulatory Mechanisms in Breast Cancer: Advances in Cellular and Molecular Biology of Breast Cancer, Chapter 19. Kluwer Academic Publishers pp 401-420
43. Borras M, Hardy L, Lempereur F, el-Khissiin AH, Legros N, Gol-Winkler R, Leclercq G 1994 Estradiol-induced down regulation of estrogen receptor. Effects of various modulators of protein synthesis and expression. J Steroid Biochem Mol Biol 48:325-336
44. Kaneko KJ, Furlow JD, Gorski J 1993 Involvement of the coding sequence for the estrogen receptor gene in autologous ligand-dependent down regulation. Mol Endocrinol 7:879-888
45. Zajchowski DA, Sager R, Webster L 1993 Estrogen inhibits the growth of estrogen receptor negative, but not estrogen receptor positive cells expressing a recombinant estrogen receptor. Cancer Res 53:5004-5011
46. Umayahara Y, Kawamori R, Watada H, Jmano E, Iwama N, Morishima T, Yamasaki Y, Kajimoto Y, Kamada T 1994 Estrogen regulation of the insulin-like growth factor I gene transcription involves an AP-1 enhancer. J Biol Chem 269:16433-16442
47. Watts CKW, Sweeney KJE, Warlters A, Musgrove A, Sutherland RL 1994 Antiestrogen regulation of cell cycle progression cyclin D1 gene expression in MCF7 human breast cancer cells. Breast Cancer Res Treat 31:95-105
48. Maminta ML, Molteni A, Rosen ST 1991 Stable expression of the human estrogen receptor in HeLa cells by infection: effect of estrogen on cell proliferation and c-myc expression. Mol Cell Endocrinol 78:61-69
49. Touitou I, Mathieu M, Rochefort H 1990 Stable transfection of the estrogen receptor cDNA into Hela cells induces estrogen respoonsiveness of endogenous cathepsin D gene but not of cell growth. Biochem Biophys Res Commun 169:109-115
50. Kraus WL, Weis KE, Katzenellenbogen BS 1995 Inhibitory cross-talk between steroid hormone receptors: differential targeting of estrogen receptor in the repression of its transcriptional activity by agonist and antagonist occupied progestin receptors. Mol Cell Biol 15:1847-1857
51. Webb P, Lopez GN, Uht RM, Kushner PJ 1995 Tamoxifen activation of the estrogen receptor/API pathway: potential origin for the cell-specific estrogen like effects of antiestrogens. Mol Endocrinol 9:443-456
52. Haber DA, Park S, Maheswaran S, Englert C, Re GG, Hazen-Martin DJ, Sens DA, Garvin AJ 1993 WT1 mediated growth suppression of Wilms' tumor cells expressing a WT1 splicing variant. Science 262:2057-2059
53. Dairkee S, Heid HW 1993 Cytokeratin profile of immunomagnetically separated epithelial subsets of the human mammary gland. In Vitro Cell Dev Biol 29A:427-432
54. Danos O, Mulligan RC 1988 Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges. Proc Natl Acad Sci USA 85:6460-6464